TrialDiabetologia2005

Cellular cholesterol efflux to plasma from moderately hypercholesterolaemic type 1 diabetic patients is enhanced, and is unaffected by simvastatin treatment.

R de Vries et al.PubMed ↗Publisher ↗

No numbers read from the abstract.